Nagahiro Saijo
- Oncology top 0.02%
- Pulmonary and Respiratory Medicine top 0.02%
- Molecular Biology top 0.5%
- Cancer Research top 0.2%
- Epidemiology top 0.5%
- Co-authors
- Yutaka NishiwakiYuichiro OheMasahiro FukuokaTomohide TamuraHaiyi JiangTony MokKazuto NishioEmma Duffield
- Topics
- Lung Cancer Treatments and Mutations (180 papers)Lung Cancer Research Studies (161 papers)Cancer therapeutics and mechanisms (141 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Nagahiro Saijo
541 papers receiving 24.7k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 16.3k
- Pulmonary and Respiratory Medicine 13.4k
- Molecular Biology 9.1k
- Cancer Research 3.5k
- Epidemiology 3.1k
Countries citing papers authored by Nagahiro Saijo
This map shows the geographic impact of Nagahiro Saijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagahiro Saijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagahiro Saijo more than expected).
Fields of papers citing papers by Nagahiro Saijo
This network shows the impact of papers produced by Nagahiro Saijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagahiro Saijo. The network helps show where Nagahiro Saijo may publish in the future.
Co-authorship network of co-authors of Nagahiro Saijo
This figure shows the co-authorship network connecting the top 25 collaborators of Nagahiro Saijo. A scholar is included among the top collaborators of Nagahiro Saijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagahiro Saijo. Nagahiro Saijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Safety and efficacy of docetaxel in prostate cancer patients: based on the post-marketing surveillance in Japan]. | 2 |
| 2 | 1 | |
| 3 | 101 | |
| 4 | 5 | |
| 5 | 31 | |
| 6 | 26 | |
| 7 | Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer. | 30 |
| 8 | 114 | |
| 9 | 23 | |
| 10 | Eg5 expression is closely correlated with response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy | 1 |
| 11 | 16 | |
| 12 | Topoisomerase I inhibitors in small-cell lung cancer. The Japanese experience. | 2 |
| 13 | 16 | |
| 14 | 38 | |
| 15 | 32 | |
| 16 | 8 | |
| 17 | Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells. | 24 |
| 18 | [Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma]. | 2 |
| 19 | 6 | |
| 20 | In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. | 42 |
About Nagahiro Saijo
Nagahiro Saijo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Microbiology, having authored 557 papers that have together received 25.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (180 papers), Lung Cancer Research Studies (161 papers) and Cancer therapeutics and mechanisms (141 papers). The work is most often cited by research in Oncology (16.3k citations), Pulmonary and Respiratory Medicine (13.4k citations) and Cancer Research (3.5k citations). Nagahiro Saijo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yutaka Nishiwaki, Yuichiro Ohe, Masahiro Fukuoka, Tomohide Tamura, Haiyi Jiang, Tony Mok, Kazuto Nishio, Emma Duffield, James Chih‐Hsin Yang and Alison Armour. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.